Patrick Commerford
Impact in
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
- Acute Myocardial Infarction Research
Papers in
-
- Atrial Fibrillation Management and Outcomes 17
- Cardiac Valve Diseases and Treatments 11
- Pericarditis and Cardiac Tamponade 8
- Cardiac electrophysiology and arrhythmias 7
- Acute Myocardial Infarction Research 6
- Cardiovascular Function and Risk Factors 5
- Surgery 28
- Lipoproteins and Cardiovascular Health 7
- Co-authors
- Salim Yusuf (12 shared papers)Maria Grazia Franzosi (2 shared papers)Bernard John Gersh (6 shared papers)Lionel Henry Opie (8 shared papers)Churchill Lukwiya Onen (2 shared papers)Steven Hawken (2 shared papers)Stephanie Ôunpuu (2 shared papers)Marc Alan Pfeffer (1 shared paper)
- Journals
- Circulation (11 papers)The Lancet (10 papers)Cardiovascular Drugs and Therapy (4 papers)American Heart Journal (4 papers)The American Journal of Cardiology (4 papers)
- Partner nations
- South AfricaUnited StatesCanada
In The Last Decade
Patrick Commerford
105 papers receiving 15.6k citations
Patrick Commerford's Hit Papers
Peers
Comparison fields: 5 of 162
- Internal Medicine 1.9k
- Cardiology and Cardiovascular Medicine 8.3k
- Surgery 3.4k
- Epidemiology 2.3k
- Endocrinology, Diabetes and Metabolism 1.1k
Countries citing papers authored by Patrick Commerford
This map shows the geographic impact of Patrick Commerford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Commerford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Commerford more than expected).
Fields of papers citing papers by Patrick Commerford
This network shows the impact of papers produced by Patrick Commerford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Commerford. The network helps show where Patrick Commerford may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Commerford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study Hit paper breakdown → | 2005 | 2316 |
| 2 | Apixaban in Patients with Atrial Fibrillation Hit paper breakdown → | 2011 | 1914 |
| 3 | Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease Hit paper breakdown → | 2017 | 1765 |
| 4 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 1106 |
| 5 | Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial Hit paper breakdown → | 2017 | 743 |
| 6 | Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range Hit paper breakdown → | 2008 | 715 |
| 7 | Controversies in ventricular remodelling Hit paper breakdown → | 2006 | 697 |
| 8 | Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 671 |
| 9 | Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 607 |
| 10 | 2003 | 566 | |
| 11 | Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin Hit paper breakdown → | 2019 | 374 |
| 12 | 2014 | 298 | |
| 13 | 2005 | 278 | |
| 14 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial Hit paper breakdown → | 2019 | 239 |
| 15 | 1987 | 238 | |
| 16 | 2003 | 235 | |
| 17 | 2016 | 231 | |
| 18 | 2009 | 226 | |
| 19 | 2013 | 181 | |
| 20 | 2010 | 175 |
About Patrick Commerford
Patrick Commerford is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Epidemiology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 110 papers that have together received 16.5k indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (17 papers), Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Valve Diseases and Treatments (11 papers), Pericarditis and Cardiac Tamponade (8 papers), Lipoproteins and Cardiovascular Health (7 papers), Cardiac electrophysiology and arrhythmias (7 papers), Acute Myocardial Infarction Research (6 papers) and Cardiovascular Function and Risk Factors (5 papers). The work is most often cited by research in Internal Medicine (1.9k citations), Cardiology and Cardiovascular Medicine (8.3k citations), Surgery (3.4k citations), Epidemiology (2.3k citations) and Endocrinology, Diabetes and Metabolism (1.1k citations). Patrick Commerford has collaborated with scholars based in South Africa, United States and Canada. Frequent co-authors include Salim Yusuf, Maria Grazia Franzosi, Bernard John Gersh, Lionel Henry Opie, Churchill Lukwiya Onen, Steven Hawken, Stephanie Ôunpuu, Marc Alan Pfeffer, Arya Mitra Sharma and Zvonko Rumboldt. Their work appears in journals such as Circulation, The Lancet, Cardiovascular Drugs and Therapy, American Heart Journal and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.